Locations:

Insight & Perspectives

19-HRT-5575-bioresorbable-scaffold-650×450

After ABSORB III: What’s Next in Bioresorbable Scaffolds?

With 5-year results now in, a lead investigator looks ahead

19-HRT-3983 chronic-total-occlusion-650×450

Treating Chronic Total Occlusions: Insights for the Nonspecialist

An expert reflects on technical advances and rising success rates

19-HRT-5577-cardiac-amyloidosis-imaging-650×450

New Recommendations on Imaging in Cardiac Amyloidosis Aim to Foster Early Recognition

How our multidisciplinary clinic models key principles from the recommendations

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-HRT-3906-Low-Dose-Aspirin-CQD
August 26, 2019/Geriatrics

Are Your Patients Using Low-Dose Aspirin for Primary Prevention of Heart Disease?

Advice for reducing high rates of inappropriate and unmonitored use

19-HRT-3880-mitral-valve_650x450

Mitral Valve Disease: When and How to Intervene?

Practical insights from two world experts in medical and surgical management

18-HRT-5576 Caputo_Image_Hero_650x450_Inset 5 left

Causes of Failed EVAR: A Cautionary Tale in Images

Some cases of AAA are still best served by open repair

Statins

Statin Intolerance: Pearls for Practice in the PCSK9 Inhibitor Era

Q&A with the director of our dedicated program for statin intolerance

19-HRT-202-Syncope-650×450

Vasovagal Syncope: What to Do When First-Line Measures Are Not Enough

Alternatives include various medications and nondrug options, but evidence is limited

BackPage 2 of 5Next

Advertisement

Ad